Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill.
This study is important because it clearly indicates the value to mothers and their [...]

The higher incidence of diabetes among African Americans when compared to whites may have more to do with living conditions than genetics, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The study, available online in advance of publication in the October 2009 edition of the Journal of [...]

GfK Healthcares Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to [...]

Marilyn Jackson, a member of Diabetes UKs UK Advisory Council, has received the Volunteer of the Year award at the firstever NHS Lothian Celebrating Success event, which took place at the Edinburgh Corn Exchange on 25 June.
The award was to recognise someone who gives freely and willingly of their time to help improve the [...]

In the July issue of Biomaterials, published by Elsevier, researchers from the University of Central Florida (UCF) report on the first labgrown motor nerves that are insulated and organized just like they are in the human body. The model system will drastically improve understanding of the causes of myelinrelated conditions, such as diabetic neuropathy and [...]

Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential for the treatment of multiple sclerosis, type 1 diabetes mellitus and numerous other autoimmune [...]

On June 26, 2009 several articles published online in Diabetologia by the European Association for the Study of Diabetes investigated the possible relationship between use of insulin glargine (Lantus, sanofiaventis) and the development of certain malignancies. The authors themselves, and the accompanying editorial, cautioned against overinterpretation of their limited data and analyses, which precluded them [...]

Diabetes UK would like to say a huge thank you to everyone who helped to make this years Diabetes Week such a great success we could not have done it without you.
Throughout the week our volunteers, supporters and staff have been busy raising funds and diabetes awareness.
Of the thousands of events that [...]

Researchers at Charles Drew University of Medicine and Science in Los Angeles and Western University of Health Sciences in Pomona have discovered a reason why smoking increases the risk of heart disease and strokes.
The study, which was presented at The Endocrine Societys 91st annual meeting in Washington, D.C., found that nicotine in cigarettes promotes insulin [...]

The value and costeffectiveness of screening for left ventricular (LV) dysfunction remains unclear, particularly since specific, evidencebased treatments are not available for the majority of patients with preserved systolic dysfunction, reports a study in the June issue of the Journal of Cardiac Failure, published by Elsevier.
In the study,1012 primary care patients with hypertension and/or diabetes [...]